Sorrento Therapeutics Inc (SRNE): BRIEF-ANVISA Authorizes Sorrento's P...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	18
Posts	1646
Boards Moderated	0
Alias Born	06/26/2014

John-Knee

Re: None

Wednesday, 10/14/2020 12:08:48 PM

Wednesday, October 14, 2020 12:08:48 PM

BRIEF-ANVISA Authorizes Sorrento's Phase 2 Clinical Trial Of Abivertinib In COVID-19 Patients
2020-10-14 11:58:39 AM ET (Reuters)

Oct 14 (Reuters) - Sorrento Therapeutics Inc:

* BRAZILIAN HEALTH REGULATORY AGENCY (ANVISA) AUTHORIZES SORRENTO THERAPEUTICS’ LARGE PHASE 2 CLINICAL TRIAL OF ABIVERTINIB IN MILD, MODERATE AND SEVERE COVID-19 PATIENTS

* SORRENTO THERAPEUTICS INC - PHASE 2 CLINICAL TRIALS OF ABIVERTINIB NOW CLEARED TO PROCEED IN BOTH BRAZIL AND U.S.

* SORRENTO THERAPEUTICS - BRAZILIAN STUDY IS EXPECTED TO RAPIDLY ENROLL 400 PATIENTS Source text for Eikon: Further company coverage:

I use both Fundamental and Technical Analysis.
Opinions posted by me are just that, my opinion.
Buy/sell any type of financial security is the sole
decision of the individual. Make your own sound
judgement or consult a professional licensed
advisor.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM